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TCM Ideology and Methodology 
The Safety-influencing Factors in Use of the Tonics of Chinese Medicine:  
A Meta-analysis Based on the Case Reports in Periodicals 
YU Jing Ѣ䴭, CUI Mengየ㩭, LI Hai-yanᴢ⍋➩, and YE Zu-guang৊⼪ܝ  
Objective: To identify the possible safety-influencing factors in use of the tonics of Chinese medicine.  
Methods: The related case reports published in periodicals published from 1949 to 2006 were analyzed with the 
bibliometrics method. Possibility on safety assessment of Chinese materia medica was discussed as well with the 
method of link analysis.  
Results: The total number of the tonics selected for the present study was 101, including 44 single drugs and 46 set 
prescriptions with adverse drug reactions (ADR) found in these tonics. It was found that ADR of 10 single drugs 
and 29 preparations were not specified in authoritative Chinese materia medica monographs. Among all the set 
prescriptions, the problem of injection has been standing on the top. Statistical analysis on single factor 
demonstrates that the most frequently referred ADR come from drug abuse (accounting for 29.20%), and overdose 
(24.54%).  
Conclusion: The safety problem of injection remains in a trend of robust growth at least for a period of time, thus 
reappraisal of the safety issue for the tonics of injection is imperative. It is essential for the public to take doctor’s 
advice to guarantee safe administration of the tonics, especially for the patients with allergic constitution or those 
suffering from the liver and heart diseases. 
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“The generalized untoward effect” refers to any adverse 
drug reactions (ADR) to drug.1 It is defined as every 
harmful effect toward human body under various 
circumstances, such as proper drug application, 
medication errors, application of clinical prescription and 
household remedies. Therefore, the ADR mentioned in 
the present study refer to the domain of “generalized 
untoward effects”. 
Sources and Collection Methods of the Case Reports 
1. Variety criteria for the tonics of Chinese medicine 
The selected drugs should be classified as tonics in 
Zhongyaoxue ( Ё 㥃 ᄺ Chinese materia medica) 
published respectively by China Press of Traditional 
Chinese Medicine in 2002, People’s Medical Publishing 
House in 2002, Press of Ancient Books of Traditional 
Chinese Medicine in 2002, Academy Press in 1998, 
China Press of Traditional Chinese Medicine in 1993, 
Hunan Science & Technology Press in 1985 and Sichuan 
Science & Technology Press in 1978. The drugs should 
be described as tonics in both Yaodian ( 㥃 ݌
Pharmacopeia, 2005 edition) and Zhongyao Dacidian (Ё
㥃໻䕲݌ Dictionary of Chinese Materia Medica). And 
the nomenclature of the drugs should be standardized 
according to Thesaurus for Traditional Chinese 
Medicine. 
2. Achieving process of the bibliographical references 
Nomen proprium was adopted to do primary retrieval of 
the key words in Bibliographic Database of TCM 
Periodicals, Chinese Biomedical Literature Database and 
Chinese Medical Current Contents Data Base with the 
time rage set from 1949 to 2006. Then, “adverse reaction, 
side effect, toxicity, intoxication and safety” were 
adopted to do secondary retrieval of the key words. 
Afterwards, unconcerned bibliographical references of 
adverse reaction of the tonics, side effect, toxicity, 
intoxication and safety were deleted, such as “Tu Ren 
Shen (Talinum Paniculatum) / toxicity”, “formaldehyde / 
toxicity, Bai Shao (Radix Paeonia Alba) / pharmacology”. 
And finally, summarizing and duplicate checking were 
conducted. 
3. File downloading and searching1
Full texts were downloaded according to bibliographical 
references from Full-text Periodical Database and 
Full-text Past Issue Database of National Knowledge 
Infrastructure (CNKI), Wanfang Full-text Database of 
Digitizing Periodicals and VIP Chinese Periodical 
Database. The full texts failed to be searched in the 
above sources should be sought from paper periodicals. 
4. Inclusion criteria 
Documents included in the present study should be ADR 
reports, which mean that detailed conditions of the cases 
should be described in the reports. Preparations involved 
in the cases should conform to one of the following 
requirements: 1) The tonic ingredients in the preparations 
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should not be those included in A Dictionary of 
Poisonous Chinese Materia Medica of the People’s 
Republic of China and their ratio in the preparations 
should be 75% or above (without consideration of the 
dosage of the medicine); 2) If the components of the 
formula are unknown, 2/3 or more of its function should 
be described as tonic. 
5. Exclusion criteria 
The documents which should be excluded: Reviews, 
notes and experiences, document analysis, duplicates of 
same cases or same subjects, cases before 1949, 
documents on toxicology and clinical safety evaluation, 
group case-reporting of ADR (case reports without 
detailed description of specific cases), case reports of 
food poisoning and case reports which are not 
correspondent with the inclusion criteria. 
Data Collection and Analysis 
1. Variety statistics: Variety statistics of the tonics of 
Chinese medicine with safety problems were collected 
respectively according to the categories of the single 
drug and the set prescription. 
2. Time analysis: Times of documents concerning drugs 
with more safety problems were collected and the 
variation trends were analyzed. 
3. Univariate analysis: the safety-influencing factors 
involved were extracted and summarized. And the single 
factors with high appearance frequency were analyzed. 
4. Link analysis of the interrelationship among various 
impacts: The WEKA software developed by Prof. ZHOU 
Xue-zhong of Beijing Jiaotong University was adopted 
for the analysis. Significant linked results were found 
after the establishment of extracting rules through data 
generalization (for example, if ten years are taken as one 
unit, the age of patients can be generalized as early youth 
group 1, youth group 1, middle aged group 1 and aged 
group 1; duration of drug application can be generalized 
as one day, one week, half a month and one month etc.). 
Result and Analysis 
1. Statistics of drug inclusion 
The total number of the tonics selected for the present 
study was 101. Their standardized names are as follows: 
Ren Shen (Radix Ginseng), Ren Shen Ye (Folium 
Ginseng), Hong Shen (Panax Ginseng), Xi Yang Shen 
(Radix Panacis Quinquefolii), Tai Zi Shen (Radix 
Pseudostellariae Heterophylly), Dang Shen (Radix 
Codonopsis), Zhu Jie Shen (Rhizoma Panacis Japonici), 
Huang Qi (Raidix Astragali), Zhi Huang Qi (Radix 
Astragali Preparata), Hong Qi (Radix Hedysari 
Manyinflorescenced), Zhi Hong Qi (Radix Hedysari 
Preparata), Bai Zhu (Rhizoma Atractylodis 
Macrocephalae), Shan Yao (Rhizoma Dioscorease), Bai
Bian Dou (Semen Lablab Album), Gan Cao (Redix 
Glycyrrhizae), Zhi Gan Cao (Radix Glycyrrhizae 
Praeparatae), Da Zao (Fructus Jujubae), Yi Tang 
(Saccharum Granorum), Feng Mi (Mel), Lu Rong (Cornu 
Cervi Pantotrichum), Lu Jiao Jiao (Colla Cornus Cervi), 
Lu Jiao Shuang (Cornu Cervi Degelatinatum), Lu Jiao 
(Cornu Cervi Elaphi), Ba J Tian (Radix Morindae 
Officinalis), Yin Yang Huo (Herba Epimedii), Xian Mao 
(Rhizoma Curculiginis), Bu Gu Zhi (Fructus Psoraleae), 
Yi Zhi (Fructus Alpiniae Oxyphyllae), Hai Gou Shen 
(Callorhinus), Hai Ma (Hippocampus), Rou Cong Rong 
(Herba Cistanches Deserticolae), Suo Yang (Herba 
Cynomorii), Tu Si Zi (Semen Cuscutae), Sha Yuan Zi 
(Semen Astragali Complanati), Du Zhong ( Cortex 
Eucommiae), Xu Duan (Radix Dipsaci), Jiu Cai Zi 
(Semen Allii Tuberosi), Yang Qi Shi (Actinolitum 
Actimolite), Hu Lu Ba (Semen Trigonellae), He Tao Ren 
(Semen Juglandis), Ge Jie (Gecko), Dong Chong Xia 
Cao (Cordyceps), Zi He Che (Placenta Hominis), Dang
Gui (Radix Angelicae Sinensis), Shud Di Huang (Radix 
Rehmanniae Praeparata), Bai Shao (Radix Paeoniae 
Alba), Zhi He Shou Wu (Radix Polygoni Multiflori 
Preparata), E Jiao (Colla Corii Asini), Long Yan Rou 
(Arillus Longan), Bei Sha Shen (Radix Glehniae), Nan 
Sha Shen (Radix Adenophorae), Bai He (Bulbus Lilii), 
Mai Dong (Radix Ophiopogonis), Tian Dong (Radix 
Asparagi), Shi Hu (Herba Dendrobii), Yu Zhu (Rhizoma 
Polygonati Odorati), Huang Jing (Rhizoma Polygonati), 
Gou Qi Zi (Fructus Lycii), Mo Han Lian (Herba 
Ecliptae), Nü Zhen Zi (Fructus Ligustri Lucidi), Sang 
Shen (Fructus Mori), Hei Zhi Ma (Semen Sesami 
Nigrum), Gui Jia (Carapax et Plastrum Testudinis), Gui 
Jia Jiao (Colla Carapacis et Plastri Testudinis), Bie Jia 
(Carapax Trionycis), Shan Mai Dong (Radix Liriopes), 
Ci Wu Jia (Radix Acanthopanacis Senticosi), Gou Ji 
(Rhizoma Cibotii), Gu Sui Bu (Rhizoma Drynariae), 
Sang Ji Sheng (Herba Taxilli), Sang Piao Xiao (Oötheca 
Mantidis), Hong Jing Tian (Radix et Rhizoma Rhodiolae 
Kirilowii), Hu Ji Sheng (Herba Visci), Yi Yi Ren (Semen 
Coicis), Ling Zhi (Ganoderma Lucidum seu Japonicum), 
Shan Zhu Yu (Fructus Corni), Lian Zi (Semen 
Nelumbinis), Hai Long (Syngnathus), Fu Pen Zi (Fructus 
Rubi Chingii), Du Zhong Ye (Folium Eucommiae), Shou
Wu Teng (Caulis Polygoni Multiflori), Ji Xue Teng 
(Caulis Spatholobi), Qian Shi (Semen Euryales), Ha Ma 
You (Oviductus Ranae), Zhu Zi Shen (Rhizoma Panacis 
Majoris), Chu Sh Zi (Fructus Broussonetiae), Xue Lian 
Hua (Herba Saussureae Laniceptis), Wu Wei Zi (Fructus 
Schisandrae), Jiao Gu Lan (Herba Gynostemmatis 
Pentaphylli), Sha Ji (Fructus Hippophae), Zi Shi Ying 
(Fluoritum), Qi Dai (Funiculus umbilicalis), Huang Gou 
Shen (Testis et Penis Callorhimi), Yang Hong Shan 
(Radix seu Herba Pimpinellae), Ming Dan Shen (Radix 
Changii), Xiong Can E (Bombyx Batryticatus), Xin’E 
Jiao (Susscrofa domestica Brisson Pigskin), Yin Er 
(Tremella Fuciformis), Feng Jiao (Colla Apis), Lu Xian 
Cao (Herba Pyrolae), Rui Ren (Nux Prinsepiae). Ten 
single drugs and twenty-nine preparations were specified 
in neither of the above 2 monographs. The 10 single 
drugs included Mai Dong (Radix Ophiopogonis), Dang 
Gui (Radix Angelicae Sinensis), Xu Duan (Radix 
Dipsaci), Lu Jiao Jiao (Colla Cornus Cervi), Bei Sha 
Shen (Radix Glehniae), Zi He Che (Placenta Hominis), 
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Gui Jia (Carapax et Plastrum Testudinis), Ming Dang 
Shen (Radix Changii), Hu Lu Ba (Semen Trigonellae) 
and Hong Jing Tian (Radix et Rhizoma Rhodiolae 
Kirilowii). The 29 preparations are Gan Cao Xin 
(Licorzine Capsules), Fufang Gancao Tianshu Zhusheye 
(໡ᮍ⫬㤝⫰㋴⊼ᇘ⎆  Compound Glycyrrhizin 
Injection), Ganlixin Zhusheye ( ⫬ ߽ ⃷ ⊼ ᇘ ⎆
Diammonium Glycyrrhizinate Injection), Shouwu Pian 
(佪Р⠛Shouwu Tablet), Shenqi Fuzheng Zhusheye (খ
㡾ᡊℷ⊼ᇘ⎆Shenqi Fuzheng Injection), Dongchong 
Xiacao Jiaonang (ހ㰿໣㤝㛊ಞDongchongxiacao
Capsule), Zhibansu (ࠊ᭥㋴Psoralen Injection), Zhenqi 
Fuzheng Chongji (䋲㡾ᡊℷކࠖZhenqi Fuzheng
Granules), Zaoren Anshen Jiaonang (ᵷҕᅝ⼲㛊ಞ
Zaoren Anshen Capsule), Yixuesheng Jiaonang (Ⲟ㸔⫳
㛊ಞ Yixuesheng Capsule), Yangxue Anshen Pian (ݏ
㸔ᅝ⼲⠛ Yangxue Anshen Tablet), Yangshen Chongji 
(⋟খކࠖYangshen Granules), Xueshan Hongjingtian 
Koufuye (䲾ቅ㑶᱃໽ষ᳡⎆Xueshan Hongjingtian
Oral Liquid), Xintong Koufuye (ᖗ䗮ষ᳡⎆Xintong
Oral Liquid), Xinganbao Jiaonang (ᖗ㙱ᅱ㛊ಞ
Xinganbao Capsule), Shengfa Wan (⫳থЌShengfa
Pill), Renshen Fengwang Jiang (Ҏখ㳖⥟⌚Ginseng 
with Royal Jelly), Nüjin Jiaonang (ཇ䞥㛊ಞNvjin
Capsule), Kang’erxin (ᒋᇨᖗKang'erxin Capsule), 
Guiyuan Bu Gao ( Ḗ ೚ 㸹 㝣  Guiyuan extract), 
Gancaosuan Dan’an Zhusheye (⫬㤝䝌ऩ㛎⊼ᇘ⎆
Ammonium Glycyrrhetate Injection), Fufang Gancao 
Tiansu (໡ᮍ⫬㤝⫰㋴⠛Compound Glycyrrhizin 
Injection), Fufang Gancaogan Pian (໡ᮍ⫬㤝䝌㣋⠛
Compound Glycyrrhizin Tablets), Fufang Ejiao Koufuye 
(໡ᮍ䰓㛊ষ᳡⎆ Compund Ejiao Oral Liquid), 
Erkangning (ܓᒋᅕ  Erkangning Syrup), Danggui 
Jisheng Zhenji (ᔧᔦᆘ⫳䩜ࠖ Danggui Jisheng
Injection), Shenqi Wuweizi Pian (খ㡾Ѩੇᄤ⠛Shenqi 
Wuweizi Tablet), Buguzhi Zhusheye (㸹偼㛖⊼ᇘ⎆
Buguzhi Injection), Ejiao Gai (䰓㛊䩭Ejiaogai Oral 
Liquid). 
2. Results and analysis with bibliometrics method 
1) Reporting frequency of single drug 
Since Ren Shen (Radix Ginseng) and Hong Shen (Radix 
Ginseng Rubra), He Shou Wu (Radix Polygoni Multiflori) 
and Zhi He Shou Wu (Radix Polygoni Multiflori 
Preparata), Gan Cao (Radix Glycyrrhizae) and Zhi Gan 
Cao (Radix Glycyrrhizae Praeparatae) were not clearly 
specified in some of the literatures, Renshen/Hongshen 
(hereinafter referred to as the single drug of Renshen), 
Heshouwu / Zhiheshouwu (hereinafter referred to as the 
single drug of Heshouwu), Gancao and Zhigancao were 
counted under unified names. 
There are 30 drugs which only involved in 1 to 2 reports, 
and 14 single drugs with 3 or more reports. The single 
drug of Renshen had the most reports with a total 
number of 50. The single drug of Heshouwu took the 
second place with total reports of 25, followed by 17 of 
the single drug of Gancao, 16 of Huang Qi (Raidix 
Astragali Membranous), 11 of Feng Mi (Mel), 10 of
Dong Chong Xia Cao (Cordyceps) and Xi Yang Shen 
(Radix Panacis Quinquefolii American ginseng) 
respectively.  
Statistics of 7 drugs which involved in more reports (10) 
were collected and listed with 10-year as a unit. See table 
1 for details. 
Table 1. Literatures on ADR of the single tonics with reports10 
Single drugs 1949-1969 1970-1979 1980-1989 1990-1999 2000-2006 Total 
Single drug of Renshen 1 1 22 20 6 50 
Single drug of Heshouwu 0 0 3 13 9 25 
Single drug of Gancao 1 0 3 11 2 17 
Huang Qi 0 0 2 7 7 16 
Feng Mi  0 1 6 1 3 11 
Dongchong Xiacao  0 0 0 8 2 10 
Xi Yang Shen 0 0 0 7 3 10 
Total 2 2 36 67 32 139 
Table 1 showed that the summit reporting of the single 
drug of Ren Shen (Ginseng), appeared in 1980s’. Since 
the concept of “ginseng abuse syndrome” was raised in 
1979 abroad, it was supposed as the reason for the 
increased cases of ginseng abuse. Resulting from those 
reports, prevention of ginseng abuse was enhanced, 
which led to dropping of the curve finally.  
Feng Mi (Mel) is often taken as a common food. Though 
the curve fluctuation is not obvious, it is quite 
incomprehensible for its ADR. However, through 
summarization and analysis, it is supposed to be caused 
by taking the unprocessed honey with honeycomb or 
toxic pollen. 
In 21 Century, the number of case reports on the above 
mentioned 7 single drugs declined. And no definite 
conclusion has been drawn yet since lack of enough 
literatures and unbalanced distribution among various 
age units. 
2) Bibliometric analysis for the set prescriptions 
There are totally 15 set prescriptions involved in 3 or 
more ADR reports, including 11 injections. Ciwujia Zhu- 
sheye (ࠎѨࡴ⊼ᇘ⎆ Ciwujia Injection) had the most 
reports of 75, followed by 49 for Huangqi Zhusheye (咘
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㡾⊼ᇘ⎆ Huangqi Injection), 48 for Shenmai Zhusheye 
(খ呺⊼ᇘ⎆Shenmai Injection) and 11 for Compound 
Ammonium Glycyrrhetate Injection (Table 2). 
Four set prescriptions involved in relatively more reports 
(10) were collected and listed in Table 3 with 10-year as 
a unit. 
Table 2. The set prescriptions with 3 cases reported on ADR 
Name of the set prescription  Number of cases reported on ADR 
Ciwujia Injection 75  
Huangqi Injection 49  
Shenmai Injection 48  
Compound Ammonium Glycyrrhetate Injection 11  
Diammonium Glycyrrhizinate Injection 8 
Shouwu Tablet 7 
Shenqi Fuzheng Injection 7 
Danggui Injection 5 
Lurongjing Injection 5 
Zhuanggu Guanjie Pill 4 
Licorzine Capsules 4 
Shengmai Injection 3 
Compound Glycyrrhizin and sodium chloride Injection 3 
Compound Danggui Injection 3 
Congrong Tongbian oral liquid 3 
Table 3. The tonics with 10 cases reported on ADR (from 1949 to 2006) 
Number of cases reported on ADR Name of the set prescriptions 
1949- 
1969  
1970- 
1979 
1980- 
1989 
1990- 
1999 
2000- 
2006 
Total 
Ciwujia Injection 0 0 0 24 50 74 
Huangqi Injection 0 0 0 11 36 47 
Shengmai Injection 0 0 2 8 37 47 
Compound Ammonium Glycyrrhetate Injection 0 0 0 4 6 10 
Total 0 0 2 47 129 178 
Notes: Five case reports for the above four injections did not mention the written year, including one for Ciwujia Injection,  
two for Huangqi Injection, and one respectively for Shenmai Injection and Compound Ammonium Glycyrrhetate Injection. 
Among all the set prescriptions, the safety issue problem 
in injection has been standing on the top, indicating that 
the safety issue of injection remains in a trend of robust 
growth at lease for a period of time, so, reappraisal of the 
safety in use of the tonics of injection is imperative.  
3) Year distribution of the case reports 
As shown in Table 4, there was only one case report on 
ADR for the tonics in the period from 1949 to 1969. In 
1970s, the number of the case reports were no more than 
6. Nevertheless, the number of the case reports have 
skyrocketed to 13.7 per year since 1990s, and the 
increasing tendency continues in this century. It is 
indicated that the public has been paying more attention 
on the safety issue of the tonics, and it reminds us that 
the development of traditional Chinese medicine would 
be affected if no proper measurements are taken in time. 
Table 4. Year distribution of the case reports on ADR for 
the tonics
Year distribution  Cases reported on ADR for the tonics 
1949-1969 1 
1970-1979 6 
1980-1989 88 
1990-1999 225 
2000-2006 269 
3. Analysis on the single factor 
‘The positive impact’ refers to the potential possibility 
leading to ADR; and it has played a key role in the safety 
issue of the tonics.  
Statistics of the single factor underlines the ADR of each 
corresponding case report respectively from negative, 
positive and no refer so as to analyze the ‘positive 
impact’ (Table 5 and Figure 1).  
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Table 5. Statistical results of the negative and positive impacts and no refer for the number of cases of ADR
Impacts   Negative (%) Positive (%) No refer (%) 
Constitution 51 (7.19) 94 (13.26) 564 (79.55) 
Pathological condition  83 (11.71) 175 (24.68) 432 (60.93) 
Compatibility 706 (99.57)  3 (0.43) 0 
Processing  6 (0.85)  1 (0.14) 702 (99.01) 
Decoction 0 0 709 (100) 
Quality    32 (4.51) 24 (3.39) 653 (92.10) 
Differentiation 58 (8.18) 29 (4.09) 622 (87.73) 
Abuse 444 (62.62) 207 (29.20) 58 (8.18) 
Drug combination 35 (4.94) 128 (18.06) 546 (77.00) 
Dose 466 (65.73) 174 (24.54) 69 (9.73) 
Figure 1. Statistics for ADR due to the positive impacts 
As shown in Figure 1, the impacts from left to right are 
Abuse, Pathological condition, Dose, Drug combination, 
Constitution, Differentiation, Quality, Compatibility, 
Processing, and Decocting. The most frequently referred 
ADR come from drug abuse (accounting for 29.20%), 
and the proportion of overdose was 24.54%. So, it is 
clear that the major causes concerning safety issue of the 
tonics are abuse and overdose.   
The percentages of impacts like ‘Pathological condition’, 
‘Drug combination’ and ‘Constitution’ are relatively 
higher than the other factors; however, from the view of 
single factor diseases of the heart, liver and kidney, drug 
combination and allergy may have potential influence on 
the safety issue of the tonics.    
4. Analysis on the linked results  
The intense distracters were excluded from the linked 
results, the interesting connections emerged in13 groups 
with the confidence coefficient 90% (Table 6).
Table 6. The linked results (confidence coefficient 90%) 
The interesting connections Confidence coefficient (%) Support coefficient (%)
Middle aged group 2==>injection 100 7.47 
Male, drug combination ==>injection 100 6.91 
Youth group 2 ==> injection 100 5.36 
Old aged group 1 ==>injection 100 5.22 
Allergic consititution ==>injection 100 5.22 
Liver disease ==> injection 100 4.94 
Female ==> injection 99.00 18.89 
Male ==> injection 99.00 16.92 
Heart disease ==> injection 99.00 10.58 
Drug combination ==> injection 98.00 11.42 
Middle aged group 1==>injection 98.00 7.76 
Heart disease, female==> vein injection  98.00 5.92 
Overdose, oral administration ==> abuse  90.00 8.46 
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There is no significant difference between ‘Female ==>
injection’ and ‘Male ==> injection’ in the support
coefficient, and their confidence coefficients are the 
same. So it is clear that one’s gender shows no 
significance in terms of ‘injection’.  
The confidence coefficients in the middle aged group 2, 
youth group 2, old aged group 1 and middle aged group 
1, are respectively 100%, 100%, 100% and 98%, with 
almost no difference among the four groups. As for the 
support coefficients in the four groups, the difference is 
also limited, they are respectively 7.47%, 5.36%, 5.22% 
and 7.76%, and the four groups happen to be connected 
from age 30 to 69. The present study shows that ADR 
strongly correlates with the people aged 30–69, but 
sufficient theoretical and data supports are needed to 
confirm the inevitability between the age range of 
‘30–69’ and ADR after injection.  
The above linked results remind us that it is necessary to 
reduce the us of injection for patients with allergic 
constitution or those suffering from the liver and heart 
diseases. For the cases with injection prescribed, the 
doctor should carefully observe the reactions, and for the 
safety reason, try to reduce the combined use of drugs so 
as to lower down the possible accidence.  
DISCUSSION 
ADR can not be simply attributed to the Drug Itself  
Many people consider the safety problem of the tonics as 
ADR and attribute all to the drug itself, sometimes 
resulting in rejection and seizure of those drugs. 
According to the definition of adverse drug reactions by 
WHO, any harmful or unexpected reactions to medicines 
which occur at normal dosage used for prevention, 
diagnosis or treatment of diseases, or for improving 
physiological functions, are called ADR. So, the 
prerequisite should be proper use of the drug.  
It was found in the present study that abuse and overdose
accounted for a considerable proportion; and the impact 
results indicated that there was a close connection 
between these two factors,. So, the ADR described in 
some case reports is the consequence of improper 
administration of the drugs. 
ADR can not be simply attributed to the drug itself, and 
the assessment should be made with abuse and overdose 
excluded.  
Enhance the Public Awareness for Safe Admini- 
stration of the Tonics 
Drug abuse commonly exists, and the public awareness 
for safe administration of the tonics should be enhanced. 
For instance, honey can be taken as food and drug; it can 
hardly be considered as the cause for ADR or the reason 
for death. In fact, the safety problems are related with the 
un-processed raw honey, which contains toxic honey-
comb or pollen. The second example is the so-called
‘Ginseng Abuse Syndrome’ caused by overdose of 
Ginseng, which in severe case may lead to death. 
Therefore, it is necessary to take doctor’s advice to 
guarantee safe administration of the tonics. 
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